Cellectar Biosciences (CLRB) Treasury Shares (2017 - 2025)
Cellectar Biosciences (CLRB) posted Treasury Shares of $111.11 for Q4 2025, little changed sequentially from $111.11 in Q3 2025, and little changed YoY from $111.11 in Q4 2024.
Cellectar Biosciences (CLRB) Treasury Shares (2017 - 2025) Analysis & Trends
Cellectar Biosciences has reported Treasury Shares for 8 years, with the latest figure at $111.11 in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $111.11 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $111.11 (changed 0.0% YoY) and the FY2025 annual result came in at $111.11, changed 0.0% from the prior year.
- Treasury Shares was little changed at $111.11 in Q4 2025 per CLRB's latest filing, from $111.11 in the prior quarter.
- Over five years, Treasury Shares peaked at $1336.1 in Q3 2023 and troughed at $111.11 in Q4 2021.
- A 5-year average of $183.17 and a median of $111.11 in 2021 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares soared 1102.51% in 2023, then plunged 91.68% in 2024.
- Over 5 years, Treasury Shares stood at $111.11 in 2021, then changed by 0.0% to $111.11 in 2022, then changed by 0.0% to $111.11 in 2023, then changed by 0.0% to $111.11 in 2024, then changed by 0.0% to $111.11 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $111.11, $111.11, and $111.11 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 2.72 Mn |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 111.11 |
| Dec 31, 2025 | 111.11 |
| Sep 30, 2025 | 111.11 |
| Sep 30, 2025 | 111.11 |
| Jun 30, 2025 | 111.11 |
| Jun 30, 2025 | 111.11 |
| Mar 31, 2025 | 111.11 |
| Mar 31, 2025 | 111.11 |
| Dec 31, 2024 | 111.11 |
| Dec 31, 2024 | 111.11 |
| Sep 30, 2024 | 111.11 |
| Sep 30, 2024 | 111.11 |
| Jun 30, 2024 | 111.11 |
| Jun 30, 2024 | 111.11 |
| Mar 31, 2024 | 111.11 |
| Mar 31, 2024 | 111.11 |
| Dec 31, 2023 | 111.11 |
| Dec 31, 2023 | 111.11 |
| Sep 30, 2023 | 1,336.11 |
| Sep 30, 2023 | 1,336.11 |